One trend in the prostate biopsy market is the new product launches and R&D activities. The vendors are concentrating on developing technologically advanced prostate cancer testing tools especially non-invasive methods. Most of the liquid biopsy companies are focusing on spending huge amount in R&D activities and developing new products to enhance the diagnosis of prostate cancer. The molecular diagnostic companies are focusing on developing advanced diagnostic tests based on mitochondrial genom 更多
